Lomecel-B Effects on Alzheimer's Disease
Trial details
- Registry ID
- NCT05233774
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Lomecel-B Effects on Alzheimer's DiseaseNCT05233774 | LGVN | Phase 2 | Completed | 2023-09-29Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |